Expression of cyclin H in normal and cancerous endometrium, its correlation with other cyclins, and association with clinicopathologic parameters


Kayaselcuk F., ERKANLI S., Bolat F., Seydaoglu G., Kuscu E., Demirhan B.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol.16, no.1, pp.402-408, 2006 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 1
  • Publication Date: 2006
  • Doi Number: 10.1111/j.1525-1438.2006.00407.x
  • Journal Name: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.402-408
  • Keywords: cyclin H, endometrial carcinoma, hyperplasia, IMMUNOHISTOCHEMICAL DETECTION, CELL, CARCINOMA, PROTEINS, P53
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

Cyclins are known as regulatory proteins in cell cycle. Cyclin H is a part of cyclin H/Cdk7/Mat1 complex, which is necessary for cellular proliferation. This study was designed to investigate the correlation of cyclin H expression with tumorigenesis of the endometrium and clinicopathologic variables. Immunohistochemical staining using labeled streptavidin-biotin complex was performed on formalin-fixed, paraffin-embedded endometrial tissues of the proliferative, hyperplastic, and carcinomatous types. Immunostaining for cyclins A, B1, D1, D3, E, H, and cyclin dependent kinase 2 were evaluated. The expression of cyclins A, D1, D3, and H in hyperplasia was significantly more frequent than those of proliferative phase and less than those of endometrioid adenocarcinoma. The expression of cyclin H was correlated with lymphvascular space invasion and clinical stage in carcinoma but not with myometrial invasion, lymph node metastasis, and menopause status. The expression of cyclin H could be involved in the transformation of the endometrium into malignancy and might be a marker for more proliferative and malignant features. It might be one of the biomarkers for determining proliferative activity in endometrial hyperplasia and endometrioid adenocarcinoma.